A - Human Necessities – 61 – N
Patent
A - Human Necessities
61
N
A61N 1/30 (2006.01) A61K 9/70 (2006.01)
Patent
CA 2634734
The present invention relates to iontophoretic transdermal delivery of nicotine salts useful for nicotine replacement therapy for an individual in need thereof. The present invention further relates to the iontophoretic transdermal delivery of nicotine maleate and nicotine citrate. Methods of reducing skin irritation generally caused by transdermal nicotine delivery by iontophoretic transdermal delivery of nicotine salts are also disclosed.
La présente invention concerne l'administration transdermique iontophorétique de sels de nicotine utiles pour une thérapie de remplacement de la nicotine chez un individu qui en a besoin. L'invention a en outre trait à l'administration transdermique iontophorétique de maléate de nicotine et de citrate de nicotine. Sont également présentés des procédés de réduction d'irritation de la peau généralement causée par l'administration transdermique de nicotine par cette administration iontophorétique de sels de nicotine.
Glaxosmithkline Llc
Gowling Lafleur Henderson Llp
Smithkline Beecham Corporation
LandOfFree
Iontophoretic transdermal delivery of nicotine salts does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Iontophoretic transdermal delivery of nicotine salts, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Iontophoretic transdermal delivery of nicotine salts will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1433575